INTERNATIONAL PATENT: CENTRICSBIO, INC., 주식회사 센트릭스바이오 FILES APPLICATION FOR "FUSION PROTEIN COMPRISING CD300C PROTEIN OR FRAGMENT THEREOF AND IMMUNOGLOBULIN FC REGION AND USE THEREOF FOR IMPROVING SKIN CONDITION"

GENEVA, March 24 -- CENTRICSBIO, INC. (3F, 28, Beobwon-ro 11-gil,Songpa-gu,Seoul 05836), 주식회사 센트릭스바이오 (서울특별시송파구법원로11길 28, 3층) filed a patent application (PCT/KR2025/014278) for "FUSION PROTEIN COMPRISING CD300C PROTEIN OR FRAGMENT THEREOF AND IMMUNOGLOBULIN FC REGION AND USE THEREOF FOR IMPROVING SKIN CONDITION" on Sep 12, 2025. With publication no. WO/2026/059389, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World ...